클라미디아감염증 편집하기 (부분)

===특징 및 고위험군===

*감염된 환자의 대부분에서 증상이 없기 때문에 전체 감염인 중에서 실제로 진단으로 확인되는 비율은 비교적 낮은 편이다.<ref name="Asymptomatic sexually transmitted diseases: the case for screening.”>Farley TA, Cohen DA, Elkins W. Asymptomatic sexually transmitted diseases: the case for screening. Prev Med 2003;36:502-509. </ref><ref name="Chlamydia trachomatis urethral infections in men.”>Stamm WE, Koutsky LA, Benedetti JK, Jourden JL, Brunham RC, Holmes KK. Chlamydia trachomatis urethral infections in men. Prevalence, risk factors, and clinical manifestations. Ann Intern Med 1984;100:47-51. </ref><ref name="Expanding efforts to prevent chlamydial infection.”>Stamm WE. Expanding efforts to prevent chlamydial infection. N Engl J Med 1998;339:768-770. </ref><ref name="Chlamydia trachomatis infections in female military recruits.”>Gaydos CA, Howell MR, Pare B, et al. Chlamydia trachomatis infections in female military recruits. N Engl J Med 1998;339:739-744. </ref><ref name="Community-based urine screening for Chlamydia trachomatis with a ligase chain reaction assay.”>Marrazzo JM, White CL, Krekeler B, et al. Community-based urine screening for Chlamydia trachomatis with a ligase chain reaction assay. Ann Intern Med 1997;127:796-803. </ref><ref name="Urine-based screening for Chlamydia trachomatis in men attending sexually transmitted disease clinics.”>Marrazzo JM, Whittington WL, Celum CL, et al. Urine-based screening for Chlamydia trachomatis in men attending sexually transmitted disease clinics. Sex Transm Dis 2001;28:219-225. </ref><ref name="Co-infection with gonorrhoea and chlamydia: how much is there and what does it mean?”>Creighton S, Tenant-Flowers M, Taylor CB, Miller R, Low N. Co-infection with gonorrhoea and chlamydia: how much is there and what does it mean? Int J STD AIDS 2003;14:109-113. </ref>

*노출에서 감염이 발생되기까지 보통 잠복기간은 2-3주이다. 그러나 6주까지 길어질 수 있다.

*치료받지 않은 감염은 수개월간 지속되어 잠복감염에 의한 성매개전파에 기여한다.

*임균에 감염된 사람 중 약 30-50%에서 클라미디아와의 동시감염이 관찰된다.<ref name="Chlamydia trachomatis among patients infected with and treated for Neisseria gonorrhoeae in sexually transmitted disease clinics in the United States.”>Lyss SB, Kamb ML, Peterman TA, et al; Project RESPECT Study Group. Chlamydia trachomatis among patients infected with and treated for Neisseria gonorrhoeae in sexually transmitted disease clinics in the United States. Ann Intern Med 2003;139:178-185. </ref><ref name="What proportion of episodes of gonorrhoea and chlamydia becomes symptomatic?">Korenromp EL, Sudaryo MK, de Vlas SJ, et al. What proportion of episodes of gonorrhoea and chlamydia becomes symptomatic? Int J STD AIDS 2002;13:91-101.</ref><ref name="The Gonococcal Resistance to Antimicrobials Programme (GRASP) Year 2007 report.”>GRASP Steering Group. The Gonococcal Resistance to Antimicrobials Programme (GRASP) Year 2007 report. London: Health Protection Agency 2008. </ref><ref name="Chlamydia trachomatis and Neisseria gonorrhoeae Prevalence and Coinfection in Adolescents Entering Selected US Juvenile Detention Centers, 1997–2002.”>KAHN RH, MOSURE DJ, BLANK S, et al. Chlamydia trachomatis and Neisseria gonorrhoeae Prevalence and Coinfection in Adolescents Entering Selected US Juvenile Detention Centers, 1997–2002. Sex Transm Dis 2005;32:255-259. </ref>

*여성에서 클라미디아에 대한 선별검사와 치료로 골반염질환의 유병률을 감소시킨다.

*클라미디아 감염의 위험인자는 다음과 같다.

:– 클라미디아에 감염된 사람과 성접촉을 한 경우

:– 최근 1년간 새로운 성 파트너 또는 2명 이상의 성 파트너와 접촉한 경우

:– 과거에 성매개감염이 있었던 경우

:– 노출위험이 많은 사람(예; 마약중독자, 수감자, 성매매 종사자, 길거리 청소년 등)